arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

STRYKER CORP

SYK
$339.04 ▲ +1.75 (+0.52%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
74 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
77
Health
Good
Neutral
auto_awesome

Analytical Summary

STRYKER CORP shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $130.0B
Dividend Yield 0.26%
Revenue Growth 9.4%
Op. Margin 25.2%
ROIC 9.5%
FCF / Share $2.76
Trailing P/E 102.1x
Price / Book
FCF Yield 0.8%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

74-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$6.59B
↑ +9.4%
Net Income Profit after all expenses
$1.28B
↑ +44.3%
Operating Margin Operating profit as % of sales
25.2%
↑ +61.9% 74th
FCF / Share Free cash flow per share
$2.76
↑ +154.8%
Long-Term Debt Long-term obligations
$14.19B
— -0.2%

Health Breakdown

Profitability
74
Financial Health
80
Cash Quality
76

Dividend History

Dividend / share · sourced from SEC filings
$1.56 Latest / share
+10.6% YoY
+11.4% 3-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters